Vicor (VICR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 revenue was $85.9M, up 2.4% sequentially but down 19.6% year-over-year; net loss was $1.2M, or $(0.03) per diluted share.
Backlog at quarter-end was $153.8M, up 2.3% sequentially but down 29.2% year-over-year; book-to-bill ratio exceeded 1 for the first time in eight quarters.
Advanced Products revenue was $46.4M, up 7.1% sequentially but down 31.3% year-over-year; Brick Products revenue was $39.5M, down 2.7% sequentially and flat year-over-year.
Cash and cash equivalents at quarter end were $251.9M, up 5.3% sequentially.
Net loss margin was (1.4)% in Q2 2024, compared to net income margin of 16.0% a year ago.
Financial highlights
Gross margin was $42.8M (49.8% of revenue), down from $55.2M (51.7%) a year ago and $45.1M (53.8%) last quarter, mainly due to product mix shift and lower-margin legacy HPC shipments.
Operating expenses were $42.6M, down 30.5% sequentially but up from $37.3M year-over-year, mainly from reduced legal fees.
Cash flow from operations was $15.6M, down from $19.0M year-over-year, but up from $2.6M sequentially; capex was $6.1M.
Inventory decreased 2.9% sequentially to $109.1M; annualized inventory turns were 1.7.
Working capital at June 30, 2024 was $367.5M; current ratio was 6.4:1.
Outlook and guidance
Management did not provide quarterly guidance due to ongoing uncertainties and a wide range of possible outcomes.
Gen 5 product sampling to customers is on track for late August, with broader releases expected in Q4 and beyond.
Company expects continued revenue concentration among fewer, larger customers and ongoing market softness in underpenetrated segments.
Ongoing supply chain and production constraints, especially for Advanced Products, may impact future results.
Company believes cash and equivalents are sufficient for operational and capital needs in the short and long term.
Latest events from Vicor
- Record 2025 results and a patent settlement set up for major 2026 growth and licensing gains.VICR
Q4 202520 Feb 2026 - Directors reelected; strategy targets growth in HPC, auto, industrial, and defense markets.VICR
AGM 20243 Feb 2026 - Q3 revenue fell year-over-year but rose sequentially, with net income of $11.6M and strong AI focus.VICR
Q3 202419 Jan 2026 - Licensing momentum, VPD innovation, and fab expansion fuel growth across key markets.VICR
28th Annual Needham Growth Conference Virtual16 Jan 2026 - Gen 5 technology ramp and legal wins drive growth, with strong momentum in key markets.VICR
27th Annual Needham Growth Conference10 Jan 2026 - Q1 revenue up 12% YoY, gross margin down, net income positive, backlog and cash up.VICR
Q1 202524 Dec 2025 - Q4 revenue and margins rose, but full-year profit fell; licensing and AI remain key focuses.VICR
Q4 202417 Dec 2025 - 2025 proxy covers board elections, executive pay, audit oversight, and governance under majority control.VICR
Proxy Filing1 Dec 2025 - Q3 2025 revenue up 18.5% YoY to $110.4M, net income $28.3M, and record licensing revenue.VICR
Q3 202529 Oct 2025